SNX7

SNX7 is a sorting nexin that operates at endocytic membranes to control protein trafficking, autophagy, and cell survival (PMID:32513819, PMID:22213104). Its PX-BAR module binds the phosphoinositides PtdIns(5)P, PtdIns(4,5)P2, and PtdIns(3,4,5)P3, consistent with peripheral association with endosomal membranes (PMID:25720158). SNX7 forms an autophagy-specific heterodimer with SNX4 (and SNX30) on tubulovesicular endocytic membranes, where it coordinates ATG9A trafficking and the recruitment of core autophagy regulators to establish productive autophagosome assembly sites (PMID:32513819). In a cargo-sorting role, SNX7 directs amyloid precursor protein (APP) to lysosomal degradation, lowering steady-state and cell-surface APP and reducing secreted Aβ and sAPPβ without altering BACE1 (PMID:29080748). SNX7 also acts as an antiapoptotic regulator: it suppresses caspase-8 activation through c-FLIP, and its loss drives caspase-8-dependent hepatoblast apoptosis that is rescued by c-FLIP(S) (PMID:22213104). In prostate cancer cells, SNX7 overexpression activates CFLIP, which weakens the ATG3–LC3A interaction and thereby inhibits autophagy (PMID:40883630).

1. 2012 High

   Established SNX7 as an antiapoptotic regulator by showing its loss activates the caspase-8 pathway, addressing whether this sorting nexin has a role in cell survival.

   Evidence Morpholino knockdown in zebrafish hepatoblasts with siRNA confirmation in culture and genetic rescue by c-FLIP(S) overexpression

   PMID:22213104

   Open questions at the time

   • Does not define how SNX7 mechanistically suppresses caspase-8/c-FLIP at the molecular level
   • Membrane/trafficking basis of the antiapoptotic effect not connected
2. 2014 Medium

   Defined the lipid-binding specificity of the SNX7 PX-BAR domain, providing the biochemical basis for membrane association.

   Evidence Recombinant human PX-BAR fragment from E. coli tested by lipid overlay assay and dynamic light scattering

   PMID:25720158

   Open questions at the time

   • In vitro lipid overlay does not establish in-cell membrane targeting
   • No structural model of the membrane-bound complex
3. 2015 Medium

   Linked reduced SNX7 to a caspase-8/IL-1β/TDO2 cascade in glia, extending the antiapoptotic axis to downstream neuroinflammatory signaling.

   Evidence Post-mortem brain tissue analysis with in vitro SNX7 downregulation and measurement of caspase-8, IL-1β, and TDO2

   PMID:26666201

   Open questions at the time

   • Causal chain from SNX7 to TDO2 not reconstituted
   • Single lab, abstract-level methods
4. 2017 Medium

   Showed SNX7 functions as a cargo sorter directing APP to lysosomal degradation, providing a trafficking mechanism with implications for Aβ production.

   Evidence Overexpression in HEK293T cells with ELISA for Aβ/sAPPβ, surface biotinylation, and lysosomal inhibitor treatment

   PMID:29080748

   Open questions at the time

   • Single overexpression approach without loss-of-function confirmation
   • Direct SNX7-APP interaction not demonstrated
5. 2020 High

   Identified the SNX4-SNX7 heterodimer as an autophagy-specific complex coordinating ATG9A trafficking, defining SNX7's core trafficking function.

   Evidence siRNA knockdown, CRISPR-Cas9 knockout, reciprocal co-IP, and image-based analysis of autophagosome assembly and ATG9A co-localization

   PMID:32513819

   Open questions at the time

   • Precise step at which ATG9A trafficking is controlled not resolved
   • How phosphoinositide binding directs heterodimer to autophagy membranes not established
6. 2025 Medium

   Connected SNX7 to autophagy inhibition in cancer via a CFLIP-ATG3-LC3A axis, in apparent contrast to its autophagy-promoting role in the SNX4 heterodimer.

   Evidence Overexpression/knockdown in prostate cancer cells with co-IP of ATG3 and LC3A and rescue experiments

   PMID:40883630

   Open questions at the time

   • Single lab, single cancer context
   • Does not reconcile autophagy-promoting versus autophagy-inhibiting roles of SNX7

• How SNX7's phosphoinositide-binding membrane activity is mechanistically coupled to its divergent roles in autophagy, cargo lysosomal sorting, and apoptosis suppression remains unresolved.
• No structural model linking lipid binding to cargo selection
• Opposing autophagy effects (SNX4 heterodimer vs CFLIP-ATG3-LC3A) not integrated
• Direct substrate/cargo interactions largely undefined